Consensus Cloud Solutions, Inc.

Good day, ladies and gentlemen, and welcome to Consensus Q4 Investor Call. My name is Tom, and I will be the operator assisting you today. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. On this call will be Scott Turecki, CEO of ConsenSys, Jim Malone, CFO, John Nebergall, COO, and Adam Varon, Senior Vice President of Finance and Accounting of ConsenSys. I will now turn the call over to Adam Varon, Senior Vice President of Finance and Accounting of ConsenSys. Thank you. You may begin.

Good afternoon. And welcome to the Consensus Investor Call to discuss Q4 2021 Preliminary Unaudited Results, 2022 Guidance, and other key information we'll share with all of you today. Joining me today are Scott Taricki, CEO, John Nevergall, COO, and Jim Malone, our newly minted CFO. The earnings call will begin with Scott providing opening remarks. John will give an update on operational progress since our Q3 investor call. And then Jim will discuss our Q4 financial results and 2022 guidance. After we finish our prepared remarks, we will conduct a Q&A session. At that time, the operator will instruct you on the procedures for asking a question. Before we begin our prepared remarks, allow me to direct you to the Safe Harbor language on slide two. As you know, this call and the webcast will include forward-looking statements. Such statements may involve risks and uncertainties that would cause actual results to differ materially from the anticipated results. Some of those risks and uncertainties include but are not limited to the risk factors outlined on slide three that we have disclosed in our Form 10 SEC filings, as well as a summary of those risk factors that we have included as part of the slideshow for the webcast. We refer you to discussions in those documents regarding safe harbor language as well as forward-looking statements. Now, let me turn the call over to Scott.

Adam, thank you very much. I'd like to add my own welcome to all the investors and analysts who are joining us for the first earnings call of consensus as we report our Q4 2021 financial results. As you can see, since we completed the spin, we've been very busy. First, making strides as an independent public company. Two, producing outstanding operating results in our first full fiscal quarter. Three, winning a significant contract servicing the Veterans Administration health system. Four, acquiring Summit Health just outside of Boston. And five, initiating our first stock repurchase program, which is an element of our capital allocation strategy. A biggest accomplishment in filling out our public company personnel has been the hiring of Jim Malone as our CFO. Jim comes with a depth of relevant experience in accounting, finance, and healthcare. He has already made a significant contribution to consensus. Welcome, Jim. He will take you through all the financial results and guidance later in the presentation. Despite the distractions of the spin and the immediate aftermath of separation, we were able to achieve the high end of the revenue range for Q4 and above the high end of both our adjusted EBITDA and non-GAAP EPS. I want to thank our employees who, despite many distractions and continuing to work from home, remain very productive. We are thrilled that after an extensive RFP process through our relationship with Cognosante, we have been chosen to be the exclusive CloudFax provider to the VA's more than 1,200 healthcare facilities. We believe that over time, this will be our single largest contract. However, this is a year of investment. We have allocated approximately $5 million to stand up and have a FedRAMP-certified system for the VA's health facilities, and we'll have the ability to market that system to other government agencies. Finally, before turning the call over to John, I would like to discuss our capital allocation strategy. Since the spin was announced, I have made it clear that we are not an M&A-focused company. In part, this is due to the number of organic efforts that we have on our plate, as well as an aggressive hiring plan over the next two years to enhance and deepen our technical team. However, we do look for acquisitions that are complementary to our product roadmap, will bring us additional customers and services, and most importantly, great teams of people. We have found such a company in Summit Health. There are opportunities for cross-selling of their HL7 and Fire products into our base, and the ability to sell consensus solutions into the Summit base, which is rich in healthcare systems utilizing the Meditech EHR solution. I would like to welcome again all the former Summit employees to Consensus. It was great to be with you in early February, and I look forward to many more meetings. John will provide you with more details on both the VA contract and the Summit acquisition shortly. Targeted M&A, such as Summit, fit nicely into our capital allocation program. To fill out that program, our board recently authorized a $100 million stock repurchase program over the next three years. This program is opportunistic with no annual goals of repurchase. As we gain more trading of our stock, we'll be making decisions as to the attractive prices for repurchase that will provide returns commensurate with our other capital allocation alternatives. I'll now turn the call over to John, who will give you more insight into our product and customer win activities.